Expanding Global Healthcare And Diagnostics Infrastructure Will Drive Future Growth

Published
06 Aug 24
Updated
06 Aug 25
AnalystConsensusTarget's Fair Value
US$169.85
20.4% undervalued intrinsic discount
06 Aug
US$135.20
Loading
1Y
-32.6%
7D
4.5%

Author's Valuation

US$169.8

20.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 7.45%

Shared on30 Apr 25
Fair value Decreased 4.99%

AnalystConsensusTarget has increased revenue growth from -1.4% to -1.7%.

Shared on23 Apr 25
Fair value Decreased 0.13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 3.25%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.95%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.81%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 16%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 14%

Shared on10 Mar 25
Fair value Decreased 9.33%

AnalystConsensusTarget has decreased revenue growth from 0.7% to -1.5% and decreased profit margin from 25.7% to 22.9%.